Clinical features and risk factors for community-onset bloodstream infections among coronavirus disease 2019 (COVID-19) patients

Akagi, Elisa; Sharma, Mamta; Johnson, Leonard B.; Szpunar, Susanna; Riederer, Kathleen; Saravolatz, Louis D.; Bhargava, Ashish

doi:10.1017/ice.2021.88

Cited by 2 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We previously reported that admission from nursing facilities was an independent risk factor for bacteremia on admission. 5 Similar findings of higher community-onset bacterial infection were reported among the patients admitted from a skilled nursing facility. 1 In our study, in-hospital mortality among patients with dual infection was 64.1%, compared to 53.1% reported in a multicenter study.…”

Section: Discussionsupporting

confidence: 71%

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

Bhargava¹,

Riederer²,

Sharma³

et al. 2021

American Journal of Infection Control

Self Cite

View full text Add to dashboard Cite

We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25.0%). Methicillin resistant Staphylococcus aureus was the predominant pathogen. Bacteremia with MDRO should be considered in the differential diagnosis among at risk populations especially those admitted from nursing facilities.

show abstract

Section: Discussionsupporting

confidence: 71%

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

Bhargava¹,

Riederer²,

Sharma³

et al. 2021

American Journal of Infection Control

Self Cite

View full text Add to dashboard Cite

show abstract

Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis

et al. 2021

View full text Add to dashboard Cite

Background: Little is known about the occurrence of bloodstream infections in hospitalized patients with COVID-19 and the related clinical consequences. The aim of this systematic review and meta-analysis was to estimate the pooled occurrence of BSIs among hospitalized patients with COVID-19 and mortality of this patient population. Methods: A systematic search was performed on PubMed, EMBASE, and Web of Science from inception to 19 April 2021. The primary outcome was the occurrence of BSIs among hospitalized patients with COVID-19. The secondary outcome was mortality at the longest available follow-up. Results: Forty-six studies met the inclusion criteria, with a total of 42,694 patients evaluated. The estimated occurrence of BSIs was 7.3% (95% CI 4.7–1.1%) among hospitalized patients with COVID-19, with a mortality rate of 41% (95% CI 30%–52.8%). The subgroup analysis conducted on patients admitted to ICU provided an estimated occurrence of 29.6% (95% CI 21.7%–38.8%). A higher occurrence of BSI was observed in patients with COVID-19, in comparison with patients without COVID-19 (OR 2.77; 95% CI 1.53–5.02; p < 0.001). Conclusions: Our analysis estimated the occurrence of BSIs among hospitalized patients with COVID-19 at around 7%. A four-times higher occurrence was estimated among patients admitted to ICU.

show abstract

Clinical features and risk factors for community-onset bloodstream infections among coronavirus disease 2019 (COVID-19) patients

Cited by 2 publications

References 11 publications

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About